$GILD News Cypress,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 8, 2014 at 12:19 PM

$GILD News

Cypress, Spansion shares rally on merger plan
5:36 p.m. Dec. 1, 2014
- MarketWatch

Mylan to manufacture, distribute Gilead Sciences HIV drug
7:49 a.m. Dec. 1, 2014
- Angela Chen

10 stocks that may revisit their highs as the year ends
10:30 a.m. Nov. 24, 2014
- Philip van Doorn

Are consumers getting gouged on health care?
9:35 a.m. Nov. 22, 2014
- Russ Britt

Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang

The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck

10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn

Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt

Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang

Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang

Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois

Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang

Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch

Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com

Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Drug Stocks Rally But Falling Crude and Energy Stocks Weigh on S&P 500

40 min ago11:39 a.m. Dec. 8, 2014
- TheStreet.com

Stocks Near Flatline as Rally in Pharmaceuticals Overshadows Energy Selloff

11:04 a.m. Today11:04 a.m. Dec. 8, 2014
- TheStreet.com

2 Core Holdings That Belong In Every Biotech Portfolio

9:45 a.m. Today9:45 a.m. Dec. 8, 2014
- Seeking Alpha

A Comprehensive Comparison Of Gilead's Harvoni And AbbVie's Triple HCV Regimen: What The HCV Marketplace May Look Like In 2015 And Beyond

9:23 a.m. Today9:23 a.m. Dec. 8, 2014
- Seeking Alpha

Cramer's Mad Money - Ulta Salon Is Looking Good (12/5/14)

5:43 a.m. Today5:43 a.m. Dec. 8, 2014
- Seeking Alpha

Best Janus Funds to Buy for 2015

12:01 a.m. Today12:01 a.m. Dec. 8, 2014
- InvestorPlace.com

Health and Tech Funds Step Up

11:06 p.m. Dec. 7, 2014
- The Wall Street Journal Interactive Edition

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

8:22 p.m. Dec. 5, 2014
- TheStreet.com

Why Gilead Is A Better Buy Than AbbVie

2:52 p.m. Dec. 5, 2014
- Seeking Alpha

Cramer Says It May Finally Be Time to Buy Laggard Gilead Sciences

12:18 p.m. Dec. 5, 2014
- TheStreet.com

Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C

9:50 a.m. Dec. 5, 2014
- benzinga.com

'Mad Money' Lightning Round: Buy, Buy, Buy Texas Instruments

6:00 a.m. Dec. 5, 2014
- TheStreet.com

Cramer's Lightning Round - Constellation Brands Has Real Magic (12/4/14)

4:36 a.m. Dec. 5, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks

8:31 p.m. Dec. 4, 2014
- TheStreet.com

Hot Drugmakers Build More Labs, Grab Space In Boston

3:47 p.m. Dec. 4, 2014
- Investors Business Daily

Gilead Sciences: An Alpha Stock Through The Good And Bad Times

3:14 p.m. Dec. 4, 2014
- Seeking Alpha

A Practical Approach To Tech Investing

9:00 a.m. Dec. 4, 2014
- Seeking Alpha

U.S. Veterans get Sovaldi for $594/pill

8:43 a.m. Dec. 4, 2014
- Seeking Alpha

Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14)

6:04 a.m. Dec. 4, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now

8:36 p.m. Dec. 3, 2014
- TheStreet.com

Gilead Presents Follow-up Data from Zydelig Registrational Studies in
Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and
Small Lymphocytic Lymphoma
10:00 a.m. Today10:00 a.m. Dec. 8, 2014
- BusinessWire - BZX

Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM
8:45 a.m. Today8:45 a.m. Dec. 8, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power
8:45 a.m. Dec. 4, 2014
- PR Newswire - PRF

Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo
8:45 a.m. Dec. 2, 2014
- PR Newswire - PRF

Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries
7:00 a.m. Dec. 1, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for Apple, Alibaba, Hewlett-Packard, Gilead Sciences, Petrobras, and BlackBerry
8:45 a.m. Nov. 26, 2014
- PR Newswire - PRF

Critical Alerts For SouFun, Petroleo Brasileiro, Gilead Sciences, Transocean and iRobot Released By InvestorsObserver
9:31 a.m. Nov. 24, 2014
- PR Newswire - PRF

Earnings Forecast Research for Kinder Morgan, Petrobras, Freeport-McMoRan, Keurig Green Mountain, Gilead Sciences, and Alibaba
8:45 a.m. Nov. 24, 2014
- PR Newswire - PRF

Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF

Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired

European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF

Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX

Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF

Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF

Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

National CORE Retains A+ Rating as Housing Demand Soars

A Rating That Speaks Volumes in Affordable Housing Fresh out of Rancho Cucamonga, National CORE's announcement of its A+ credit rating reaffirmation is no small potatoes. For the fourth consecutive year, Standard & Poor's Global Ratings has found that this nonprofit affordable housing developer checks all the right boxes for financial strength and strategic prowess. It's...

Capacity LLC: Finalist in 2026 BeautyMatter Awards

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Ecopetrol Sets Q3 2026 Results Release, Conference Call

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

DFW Cash Offers: Better Way Home Solutions' Edge

Cash Offers in the Real Estate Maze In Dallas–Fort Worth, selling a home isn't your TV show montage. It's a challenging minefield of tenant headaches, quick moves, and foreclosure pressures. You know, sometimes it's not even about staging photos and waiting for that glamorous open house. Nope, some folks just need cash—and fast. Why Cash is King in DFW Let's cut the...

U.S. Gold Corp. Gears Up for Key October Event

Marking Calendars for the Emerging Growth Showdown There's nothing quite like the buzz leading up to an event where you know someone’s either gonna make a splash or barely leave a ripple. U.S. Gold Corp. is drawing some attention ahead of the Emerging Growth Conference on October 29, 2026. This ain't just any corporate dog-and-pony show—it's a chance for the Gold...

Justin Boots Revamps Ada with Bold New Colors

Reimagining a Western Favorite Howdy, folks! A staple in the Western wear scene just got a fresh paint job, and it's got people talking from Fort Worth to far beyond. The beloved Ada boot from Justin Boots is sashaying its way back in five fresh colorways that slap a modern twist on a vintage favorite. It's like trying to breathe some new life into an old rodeo star,...

Strategic Resources Faces Board Shakeup, AGM Announced

A Shift in Strategic Resources' Boardroom Dynamics On days like these, companies aren't just ticking boxes. They're repositioning themselves for a future painted with a whole bunch of ‘what ifs’, and Strategic Resources Inc. is no exception. This isn’t just your run-of-the-mill board shuffle—Michael Moore’s resignation marks a pivot moment. Now, you might ask...

MTB Auction Spotlights 61 Lots of Key CNC Equipment

A Windfall of Opportunities for Equipment Buyers The hum of CNC machines, the clang of fabrication tools—it's the symphony of progress echoing from workshops around the world. Machine Tool Bids (MTB) is rolling out the red carpet for manufacturing enthusiasts with its October 28 auction. How often do you get a shot at 61 lots of top-tier metalworking equipment at your...

Unlocking Airbnb Success: Expert Tips on Design Features

Design's Role in Capturing Airbnb Guests Alright, folks, let's dissect what really gets those Airbnb bookings. Wendy Anguiano, no stranger to sprucing up coastal rentals, dishes the dirt on design elements that scream 'book me' on first click. She's hailed from Design & Dwell Homes, operating right from the heart of Santa Rosa Beach, Florida. It's a fierce market out...

San Diego's Iconic Nightlife Venue Revives as The Quin

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...